Receptors, Vasoactive Intestinal Peptide
"Receptors, Vasoactive Intestinal Peptide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface proteins that bind VASOACTIVE INTESTINAL PEPTIDE; (VIP); with high affinity and trigger intracellular changes which influence the behavior of cells.
MeSH Number(s)
D12.776.543.750.100.900
D12.776.543.750.720.600.915
D12.776.543.750.750.360.900
D12.776.543.750.750.555.915
Concept/Terms
Receptors, Vasoactive Intestinal Peptide- Receptors, Vasoactive Intestinal Peptide
- Vasoactive Intestinal Peptide Receptors
- VIP Receptors
- VIP Receptor
- Receptor, VIP
- Receptors, VIP
- Vasoactive Intestinal Peptide Receptor
Below are MeSH descriptors whose meaning is more general than "Receptors, Vasoactive Intestinal Peptide".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.100]
- Receptors, Vasoactive Intestinal Peptide [D12.776.543.750.100.900]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Neuropeptide [D12.776.543.750.720.600]
- Receptors, Vasoactive Intestinal Peptide [D12.776.543.750.720.600.915]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Gastrointestinal Hormone [D12.776.543.750.750.360]
- Receptors, Vasoactive Intestinal Peptide [D12.776.543.750.750.360.900]
- Receptors, Neuropeptide [D12.776.543.750.750.555]
- Receptors, Vasoactive Intestinal Peptide [D12.776.543.750.750.555.915]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Vasoactive Intestinal Peptide".
This graph shows the total number of publications written about "Receptors, Vasoactive Intestinal Peptide" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Vasoactive Intestinal Peptide" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 1 | 2 |
1998 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
Below are the most recent publications written about "Receptors, Vasoactive Intestinal Peptide" by people in Profiles.
-
Vasoactive intestinal peptide regulates ileal goblet cell production in mice. Physiol Rep. 2020 02; 8(3):e14363.
-
VIP induces NF-?B1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells. Cell Signal. 2015 Feb; 27(2):236-44.
-
VPAC receptor signaling modulates grouping behavior and social responses to contextual novelty in a gregarious finch: a role for a putative prefrontal cortex homologue. Horm Behav. 2013 Aug; 64(3):511-8.
-
Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation. Biochim Biophys Acta. 2012 Oct; 1823(10):1676-85.
-
Chronic stimulation of the hypothalamic vasoactive intestinal peptide receptor lengthens circadian period in mice and hamsters. Am J Physiol Regul Integr Comp Physiol. 2010 Jul; 299(1):R379-85.
-
Vasoactive intestinal peptide acts via multiple signal pathways to regulate hippocampal NMDA receptors and synaptic transmission. Hippocampus. 2009 Sep; 19(9):779-89.
-
Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone. Int J Oncol. 2007 Nov; 31(5):1223-30.
-
Shark rectal gland vasoactive intestinal peptide receptor: cloning, functional expression, and regulation of CFTR chloride channels. Am J Physiol Regul Integr Comp Physiol. 2006 Oct; 291(4):R1157-64.
-
Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells. Mol Cell Endocrinol. 2006 Apr 25; 249(1-2):116-22.
-
Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: antagonistic action of a growth-hormone-releasing hormone analog. Int J Oncol. 2005 Jun; 26(6):1629-35.